SPC440
Somatrogon
Status:
UmsóknApplication date:
20.9.2023Application published:
15.10.2023
Max expiry date:
13.2.2037Medicine name:
NgenlaMedicine for children:
No
Timeline
Today
20.9.2023Application
15.10.2023Publication
13.2.2037Expires
Marketing license
IS authorization number:
EU/1/21/1617Date:
22.2.2022
Foreign authorization number:
EU/1/21/1617Date:
14.2.2022
Owner
Name:
OPKO Biologics Ltd.Address:
16 Ashlegan Street, Kiryat Gat, 8211804 IL
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113 Reykjavík
Patent
Number:
EP3230309